Saltar al contenido
Quant500 - Análisis Cuantitativo
Buscar ticker o empresa...
ES | EN

Compras y ventas de directivos de Equifax (EFX)

Que te avisemos cuando un directivo compre Las compras en mercado abierto son raras: el directivo pone su propio dinero. Un correo el mismo día que llega el Formulario 4, con el documento enlazado. Hace falta una cuenta gratuita, y el aviso llega apagado: lo enciendes tú cuando quieras.

Qué compran y venden los consejeros y directivos del S&P 500 en sus propias empresas, tal cual lo presentan en los Formularios 4 de la SEC (2 días hábiles de plazo): cada fila con su código oficial y sin filtrar nada.

Las compras en mercado abierto (código P) son la señal rara, en verde; las ventas (código S) son frecuentes y muchas van programadas (10b5-1). La tabla II (derivados) no se incluye: sus precios son de ejercicio, no de mercado. Guía: compras de directivos.

Cargando…
Más filtros

Compras y ventas de directivos declaradas en el Formulario 4 de la SEC: fecha, empresa, directivo, cargo, acciones, precio, importe, porcentaje de la posición y tipo de operación.
Fecha Ticker Directivo Cargo Acciones Precio Importe % posición Tipo / documento

Descargar estas transacciones en CSV Sin cuenta y sin registro. Los datos son públicos: salen de los Formularios 4 de la SEC.

Compras y ventas de directivos de Equifax Inc. (EFX): 1 compra y 13 ventas

69 transacciones de la tabla I del Formulario 4 declaradas ante la SEC por directivos de Equifax Inc. entre el 2025-10-28 y el 2026-09-08 (histórico de 15 meses): 1 compra y 13 ventas en mercado abierto, y 55 transacciones con otros códigos del Formulario 4, desglosados uno a uno más abajo. La mayor operación en mercado abierto es una venta de $11,4M de Begor Mark W el 2025-10-27.

Compras y ventas de directivos de Equifax en los últimos 12 meses

Entre el 21 oct 2025 y el 20 oct 2026, los directivos de Equifax declararon 1 compra por $465k y 13 ventas por $38,5M en mercado abierto. El saldo neto es vendedor: salen $38,0M más de los que entran.

Quien más compró fue Mao Cecilia (EVP, Chief Product Officer): $465k en 1 compra, el único comprador. Quien más vendió fue Begor Mark W (CEO): $32,1M en 4 ventas, de 4 vendedores distintos.

La mayor operación del período fue una venta de $11,4M el 27 oct 2025, de Begor Mark W (CEO), dentro de un plan 10b5-1. Formulario 4 en sec.gov (0001225208-25-008793).

Las 13 ventas llevan en el Formulario 4 la marca de plan 10b5-1: todas estaban programadas con meses de antelación. La única compra también estaba programada en un plan 10b5-1.

En los tres últimos meses hay 0 compras y 2 ventas, frente a 0 y 3 en los tres anteriores. La última compra es del 18 feb 2026; la última venta, del 3 sept 2026.

Frente a su sector (Industria, 75 empresas con página de directivos en esta web), en las mismas fechas la mediana es de 8 ventas y 0 compras en mercado abierto. Equifax tiene más ventas que 50 de las otras 74, es la 21.ª de 75 por dinero neto vendido, y 28 de las 75 tienen al menos una compra, Equifax incluida.

Las 20 operaciones más importantes

Primero la única compra en mercado abierto y después el resto, cada tipo de mayor a menor importe. El histórico completo está en la herramienta de arriba, ya buscado.

Ver las 69 operaciones de EFX en el histórico completo →

OperaciónDeclaradaDirectivoCargoImporteCódigoDocumento
2026-02-182026-02-19Mao CeciliaEVP, Chief Product Officer$465kP — Compra en mercado abierto (programada 10b5-1)
2 notas del Formulario 4 (texto original de la SEC, en inglés)

F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/18/2025.

F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

SEC
2025-10-272025-10-29Begor Mark WCEO$11,4MS — Venta en mercado abierto (programada 10b5-1)

Tenencia indirecta, a través de: 2-yr Jun 2025 GRAT

15 notas del Formulario 4 (texto original de la SEC, en inglés)

F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/14/2024.

F3 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $233.795 to $234.215, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 199 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan.

F4 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $234.93 to $235.43, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F5 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $230.74 to $231.734, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F6 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $232.74 to $233.72, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F7 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $228.73 to $229.72, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F8 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $229.74 to $230.72, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F9 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $231.735 to $232.71, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F10 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $233.88 to $234.215, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F11 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $232.85 to $233.80, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F12 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $230.83 to $231.82, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F13 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $228.73 to $229.685, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F14 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $231.845 to $232.81, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F15 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $229.7507 to $230.7266, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

SEC
2026-02-102026-02-12Begor Mark WCEO$7,6MS — Venta en mercado abierto (programada 10b5-1)
13 notas del Formulario 4 (texto original de la SEC, en inglés)

F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 10/28/2025.

F3 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $197.524 to $198.008, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 199 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan.

F4 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $203.675 to $203.85, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F5 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $192.556 to $193.366, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F6 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $193.735 to $194.661, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F7 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $194.892 to $195.779, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F8 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $196.123 to $196.912, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F9 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $198.645 to $199.62, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F10 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $199.67 to $200.481, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F11 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $200.672 to $201.66, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F12 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $202.665 to $203.64, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F13 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $201.67 to $202.66, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

SEC
2026-04-242026-04-28Begor Mark WCEO$6,5MS — Venta en mercado abierto (programada 10b5-1)
6 notas del Formulario 4 (texto original de la SEC, en inglés)

F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 10/28/2025.

F3 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $173.98 to $174.78, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 280 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan.

F4 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $172.986 to $173.975, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F5 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $170.982 to $171.979, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F6 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $171.986 to $172.975, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

SEC
2026-07-242026-07-28Begor Mark WCEO$6,5MS — Venta en mercado abierto (programada 10b5-1)
10 notas del Formulario 4 (texto original de la SEC, en inglés)

F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 10/28/2025.

F3 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $175.74 to $175.94, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 226 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan.

F4 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $169.42 to $170.09, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F5 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $168.395 to $168.55, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F6 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $174.54 to $175.48, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F7 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $173.50 to $174.15, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F8 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $172.50 to $173.33, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F9 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $170.48 to $171.47, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F10 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $171.50 to $172.49, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

SEC
2026-02-102026-02-12Farshchi JamilEVP, Chief Technology Officer$1,2MS — Venta en mercado abierto (programada 10b5-1)
2 notas del Formulario 4 (texto original de la SEC, en inglés)

F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 4/25/2025.

F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 400 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan.

SEC
2025-10-272025-10-28Farshchi JamilEVP, Chief Technology Officer$1,2MS — Venta en mercado abierto (programada 10b5-1)
2 notas del Formulario 4 (texto original de la SEC, en inglés)

F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 4/25/2025.

F1 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 372 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan.

SEC
2026-02-232026-02-25Gamble John W JrEVP, CFO & COO$881kS — Venta en mercado abierto (programada 10b5-1)
2 notas del Formulario 4 (texto original de la SEC, en inglés)

F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/21/2025.

F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

SEC
2026-09-032026-09-08Gamble John W JrEVP, CFO & COO$846kS — Venta en mercado abierto (programada 10b5-1)
2 notas del Formulario 4 (texto original de la SEC, en inglés)

F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/28/2026.

F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

SEC
2026-05-012026-05-05Gamble John W JrEVP, CFO & COO$618kS — Venta en mercado abierto (programada 10b5-1)
2 notas del Formulario 4 (texto original de la SEC, en inglés)

F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/21/2025.

F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

SEC
2025-11-202025-11-21Gamble John W JrEVP, CFO & COO$521kS — Venta en mercado abierto (programada 10b5-1)
2 notas del Formulario 4 (texto original de la SEC, en inglés)

F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/14/2025.

F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

SEC
2026-02-122026-02-17Borton Chad MEVP, Pres Workforce Solutions$485kS — Venta en mercado abierto (programada 10b5-1)
2 notas del Formulario 4 (texto original de la SEC, en inglés)

F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/4/2025.

F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

SEC
2026-05-072026-05-08Borton Chad MEVP, Pres Workforce Solutions$427kS — Venta en mercado abierto (programada 10b5-1)
2 notas del Formulario 4 (texto original de la SEC, en inglés)

F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/4/2025.

F1 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

SEC
2026-02-112026-02-12Farshchi JamilEVP, Chief Technology Officer$233kS — Venta en mercado abierto (programada 10b5-1)
2 notas del Formulario 4 (texto original de la SEC, en inglés)

F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 4/25/2025.

F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 400 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan.

SEC
2025-10-272025-10-29Begor Mark WCEO$5,4MM — Ejercicio de opciones (programada 10b5-1)
2 notas del Formulario 4 (texto original de la SEC, en inglés)

F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/14/2024.

F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 199 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan.

SEC
2026-07-242026-07-28Begor Mark WCEO$4,2MM — Ejercicio de opciones (programada 10b5-1)
2 notas del Formulario 4 (texto original de la SEC, en inglés)

F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 10/28/2025.

F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 226 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan.

SEC
2026-04-242026-04-28Begor Mark WCEO$4,2MM — Ejercicio de opciones (programada 10b5-1)
2 notas del Formulario 4 (texto original de la SEC, en inglés)

F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 10/28/2025.

F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 280 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan.

SEC
2026-02-102026-02-12Begor Mark WCEO$4,2MM — Ejercicio de opciones (programada 10b5-1)
2 notas del Formulario 4 (texto original de la SEC, en inglés)

F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 10/28/2025.

F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 199 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan.

SEC
2026-02-102026-02-12Gamble John W JrEVP, CFO & COO$1,4MF — Retención fiscal (acciones entregadas por impuestos)
Nota del Formulario 4 (texto original de la SEC, en inglés)

F1 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

SEC
2026-02-102026-02-12Farshchi JamilEVP, Chief Technology Officer$1,2MM — Ejercicio de opciones (programada 10b5-1)
2 notas del Formulario 4 (texto original de la SEC, en inglés)

F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 4/25/2025.

F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 400 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan.

SEC

El saldo del período: cuánto dinero entra y cuánto sale

En los Formularios 4 presentados entre el 28 oct 2025 y el 8 sept 2026, el mercado abierto de Equifax Inc. suma 1 compra por $465k y 13 ventas por $38,5M. El saldo es de $38,0M a favor de las ventas.

Solo cuentan los códigos P y S, donde el directivo pone o saca su propio dinero. Que el saldo de Equifax Inc. salga vendedor es lo habitual en el S&P 500, donde buena parte del sueldo se cobra en acciones. No es una recomendación de comprar ni de vender: es lo que se declaró.

Todas las transacciones, código por código

CódigoQué significaOperacionesImporte declarado
AAdjudicación o premio de acciones31$2,0M
FRetención fiscal (acciones entregadas por impuestos)17$5,5M
SVenta en mercado abierto13$38,5M
MEjercicio de opciones6$20,2M
GRegalo o donación1$0
PCompra en mercado abierto1$465k
TotalTodo lo declarado en el período69$66,6M

23 de las 69 filas no traen un importe utilizable en el Formulario 4: cuentan como operación y suman $0. Las etiquetas son las del índice de códigos de la SEC.

Quién ha operado

En los 15 meses del histórico han declarado operaciones de Equifax Inc. 22 personas o entidades distintas. De ellas, 1 compró en mercado abierto y 4 vendieron. Se cuentan por su CIK, el número fijo que la SEC da a cada declarante, y no por el nombre, que cada uno escribe a su manera.

DeclaranteCargoTransaccionesComprado (nº)Vendido (nº)Última declarada
Begor Mark WCEO15—$32,1M (4)2026-07-28
Gamble John W JrEVP, CFO & COO8—$2,9M (4)2026-09-08
Farshchi JamilEVP, Chief Technology Officer8—$2,6M (3)2026-02-27
Borton Chad MEVP, Pres Workforce Solutions4—$912k (2)2026-05-08
Mao CeciliaEVP, Chief Product Officer4$465k (1)—2026-02-27
Chaney CarlaEVP, Chief HR Officer4——2026-02-27
Houston Julia AEVP, Chief Legal Officer4——2026-02-27
Bindal SunilEVP, Chief Corp Dev Officer3——2026-02-27

Se enseñan los 8 que más dinero movieron, de 22. Los demás están en el histórico completo, que se abre con el enlace de arriba. El nombre lleva a todas sus operaciones, en cualquier empresa. «Transacciones» cuenta cualquier código; el dinero, solo mercado abierto. Cargo: el de su última declaración.

Mes a mes

Por el mes en que se operó, no en el que se presentó el formulario; los meses sin operaciones van a cero. El mes con más movimiento fue feb 2026: 1 compra y 5 ventas, por $10,9M. 8 de los 15 meses no tienen ninguna.

MesComprasImporteVentasImporte
ago 20250$00$0
sept 20250$00$0
oct 20250$02$12,6M
nov 20250$01$521k
dic 20250$00$0
ene 20260$00$0
feb 20261$465k5$10,4M
mar 20260$00$0
abr 20260$01$6,5M
may 20260$02$1,0M
jun 20260$00$0
jul 20260$01$6,5M
ago 20260$00$0
sept 20260$01$846k
oct 20260$00$0

El último mes puede ir incompleto: el Formulario 4 se presenta hasta dos días hábiles después. La tabla no dice si el patrón es bueno o malo; dice cuándo pasó.

Ficha de análisis de Equifax Inc. (EFX) →

Otras empresas de Industria con operaciones de directivos

Están las 500 en el índice de la sección →

Qué directivos están comprando acciones de su propia empresa →

Cómo leer estos datos

13 de las 13 ventas de la tabla van marcadas como programadas (plan 10b5-1): se firman con meses de antelación y se ejecutan solas, así que no dicen lo que el directivo piensa hoy. La única compra en mercado abierto (código P) de Equifax es la señal rara: los directivos ya cobran en acciones, y comprar más es poner dinero propio. La última presentación es del 8 sept 2026, y el Formulario 4 llega hasta dos días hábiles después de operar.

20 de las 20 filas de la tabla llevan notas al pie del propio Formulario 4, plegadas en la columna del código y copiadas tal cual, en inglés; una fila sin nota es que el formulario no la trae.

Guía: Compras de directivos · todas las guías

Lo que hay detrás de estas operaciones

Los conceptos de esta página, explicados desde cero en la Academia. Gratis y sin cuenta.

La Academia entera, curso a curso →

Fuente: SEC EDGAR Formulario 4. Esto es una lista de hechos públicos, no asesoramiento financiero ni una recomendación de compra o venta.

La cartera del modelo, cada semana en tu correo

Cada sábado, su semana en un minuto: cómo fue, lo mejor y lo peor, y qué directivos compraron con su dinero. Y el día que el modelo se rehace, qué entra y qué sale. Es una simulación, no un consejo. Como mucho un correo a la semana, sin publicidad y sin cuenta; te das de baja con un clic. Lo hace una persona: Pol Gracia.

Cartera modelo con resultados simulados, no una recomendación personalizada. Tu correo se usa solo para esto: privacidad.

Gravedad del S&P 500